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Young onset dementia is associated with distinctive support needs but existing research on service 
provision has been largely small scale and qualitative. Our objective was to explore service use, 
cost and satisfaction across the UK.  
 
Methods 
Information about socio-demographic characteristics, service use and satisfaction were gathered 
from people with young onset dementia and/or a family member/supporter via a national survey.  
 
Results  
Two hundred and thirty-three responses were analysed. Diagnosis was most commonly received 
through a Memory Clinic or Neurology. The type of service delivering diagnosis impacted on post-
diagnostic care. Those diagnosed in specialist young onset dementia services were more likely to 
receive support within the first six weeks and receive ongoing care in the service where they were 
diagnosed. Ongoing care management arrangements varied but generally care was lacking. Around 
42% reported no follow-up during 6-weeks after diagnosis; over a third reported seeing no health 
professional within the previous three months; just over a third had a key worker and just under a 
third had a care plan. Satisfaction and quality of care were highest in specialist services. Almost 
60% of family members spent over 5 hours per day caring; Median costs of health and social care, 3 
months, 2018, were £394 (IQR £389 to 640).  
 
Conclusions 
Variation across diagnostic and post-diagnostic care pathways for young onset dementia leads to 
disparate experiences, with specialist young onset services being associated with better continuity, 






quality and satisfaction.  More specialist services are needed so all with young onset dementia can 
access age-appropriate care.  
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Key points (up to 4) 
• In the absence of detailed information on service use, costs and satisfaction for people with 
young onset dementia, a large national cross-sectional, self-report survey was conducted of 
people with young onset dementia and/or close supporters, receiving 233 usable responses.  
• Nearly sixty percent of family members /supporters provided over 5 hours of care a day for 
the person with young onset dementia, with family members’/supporters’ care being valued 
at over 20 times the cost of support from formal services. 
• The majority of respondents were mostly or very satisfied with their care from services with 
higher satisfaction being associated with being managed by a specialist service and knowing 
who to contact with questions;  reporting nobody or a GP alone managed care on a regular 
basis was associated with lower satisfaction.  
• Specialist young onset dementia services performed better than other types of service on 
quality indicators, including provision of support in the immediate period after diagnosis, , 











Although dementia predominantly affects older people, an estimated 5.5% of those diagnosed have  
young onset dementia (YOD; where symptoms develop <65 years 1. UK numbers are estimated as 
42,325 2. Those living with YOD have distinctive and wide-ranging needs due to age, life stage 3-6, 
and the range of rare diagnoses 7. Specialised, tailored, well-integrated YOD services, that provide 
continuity of care, are widely seen as central to addressing these challenges (8-13). Available 
evidence, however, indicates problematic issues and gaps in provision. Delays to diagnosis and 
misdiagnosis are common 8,11 due to the rarity of YOD and the heterogeneity of presenting 
symptoms, which leads to multiple pathways to diagnosis 13,14. In addition, effective post-diagnostic 
services are lacking 15. In a recent UK-wide survey of healthcare professionals involved in services 
for YOD, 54% reported no access to a consultant with a special interest, 28% reported no post‐
diagnostic support and only 25% reported access to age‐specific post‐diagnostic support 16. 
Consultation with people with YOD and family carers 17-18 highlights key barriers to post-diagnostic 
support, including lack of: age-appropriate services information to allow timely access, and poor 
service continuity in the transition from diagnosis to post-diagnostic support.  
Existing studies on post-diagnostic YOD services have tended to be small-scale and qualitative, 
with a lack of information on service costs 8,11,12 . This paper reports the findings from a large-scale, 
UK-wide survey of people living with YOD and carers. The aim was to gather baseline information 
on current YOD service delivery and explore how patterns of care link to quality of care, user 
satisfaction and costs, in order to inform commissioning and service provision.    
 
Methods     
 






A cross-sectional UK-wide survey was conducted, gathering data from people with YOD and/or an 
involved family member or supporter (referred to from hereon as ‘family member’) on socio-
demographic characteristics, service use, satisfaction and positive experiences of support. This 
article reports the service use, cost and satisfaction data. 
 
Measures 
The survey (Supplementary material: S1) was developed by the research team and piloted twice 
with members of the project patient and public involvement group to ensure wording and questions 
were suitable. It included four parts. Part 1 comprised open-ended questions on positive experiences 
of service support (reported elsewhere 19). and a 7-point Likert-scale rating of overall satisfaction 
with quality of services. Part 2 requested socio-demographic information about the person with 
YOD (age, gender, diagnosis, when symptoms appeared, date of diagnosis, number of prescription 
medications, how long the person could be alone, household composition, place of residence, 
educational level, occupation, employment status, income). Part 3 asked similar socio-demographic 
questions about family members, their time spent caring, extra hours on household tasks since 
diagnosis, supplementary help from others, and frequency of any respite services. Part 4 asked the 
type of service in which the person received the diagnosis and had regular follow-up (YOD-
specialist service, memory clinic, older people’s mental health, neurology, general practitioner), 
diagnostic tests, frequency of follow-up appointments and support and services accessed in the past 
3 months (6 months for hospital admissions). Four quality of care indicators were embedded (seeing 
the same professional at each appointment, having a care plan, having a key worker, knowing who 
to contact with questions about treatment and care). Questions mostly employed a yes/no or 
multiple-choice format. 
 






The opening question of the survey filtered respondents to four different completion pathways 
(person with YOD alone, with family member or with paid carer or family member alone). Wording 
was customised accordingly (e.g. referring to ‘you’ for person with YOD and ‘the person with 
YOD’ when a family member was the respondent).   
 
Participants 
Those with a confirmed YOD diagnosis and family members/supporters were eligible to participate. 
People with dementia related to Down’s syndrome, HIV, traumatic brain injury, Huntington’s 
disease or alcohol-use were excluded, as these populations usually access different services. 
Participants were recruited through 14 UK National Health Service sites, purposively selected to 
include different diagnostic pathways (specialist YOD services, neurology, generic dementia 
services). A wide range of third-sector organisations also advertised the survey and information was 
distributed via Join Dementia Research, a UK National Institute of Health Research register of 
potential participants. Sample size was not pre-defined but we aimed to recruit as many participants 
as possible.   
 
Procedure 
Health Research Authority ethical approval was granted (South Central Berkshire Research Ethics 
Committee, REC ref.: 17/SC/0296) and data were collected between August 2017 and September 
2018. The survey was available through the user-friendly, Bristol Online Surveys platform 
(https://www.onlinesurveys.ac.uk). Paper copies could be requested from the researchers. Capacity 
to consent was assumed for those completing on paper or online. Respondents were invited to 
contact the researchers for help if necessary, in which case, capacity to consent was assessed, 
written consent was obtained and survey completion was conducted via Skype, telephone or face-
to-face. Following completion, a list of national sources of support was provided to all respondents.   








Responses to individual questions were combined across survey completion pathways.  For 
analyses that compared completion pathways, responses from a person with YOD assisted by a paid 
carer were combined with responses from the person with YOD alone, since numbers were small 
and, in both pathways, responses provided the perspective of the person with YOD.  For 
comparative analysis concerning diagnoses, these were grouped into: Alzheimer, Vascular and 
mixed Vascular/ Alzheimer, Rest (Frontotemporal, Posterior Cortical Atrophy, Lewy body, other, 
unspecified). Background characteristics were analysed descriptively and compared between 
pathways using appropriate statistical tests. 
 
Provision of tests at diagnosis and referral to post diagnostic services were compared across types 
of service in which diagnoses were given.  Services received in the last three months (including 
informal care) were analysed descriptively.  Exploratory analyses included: continuity between the 
type of service attended for diagnosis and for follow-up care; associations between diagnosis and 
frequency of appointments with the service seen the most; associations between the type of service 
managing follow-up care and participant location (urban vs rural), frequency of follow-up 
appointments, time since diagnosis, number of different health professionals seen and activities 
attended by the person with YOD in the previous three months, quality of care and satisfaction 
indicators.  
 
Costs of care (British pounds 2018) were calculated over a 3-month period, based on reported 
service use, in five groups: nurses and allied health professionals, medical, hospital inpatient, social 
care, family care (Supplementary material, S3 gives details and unit costs).  
 






Multiple linear regression was performed for three outcome variables: satisfaction with care, total 
cost of health and social care, informal caring hours.  Predictor variables included the characteristics 
of the person with YOD and the services they received (see Results for full list). Backward 
elimination was used to derive an initial model. This was then rerun with just the statistically 
significant predictor variables, to maximise the number of observations used, owing to the presence 
of scattered missing data. 
 
Results    
 
Sample characteristics  
There were 233 usable responses20. Data were obtained about the person with YOD from all 
responses (n=233) and from 185 family members (when a family member was involved in 
completion). In over half the responses, a person with YOD was involved in survey completion, 
alone (n=39, 16.7%), with a paid carer (n=9, 3.9%) or with a family member (n=84, 36.1%). There 
were 101 (43.3%) family members completing the survey on their own, meaning family members 
were involved in almost 80% of all responses. There were no statistically significant differences 
between survey completion pathways on any characteristic related to the person with YOD or 
family member (data not shown).  
 
Those with YOD were evenly divided between women and men, with a mean age of 62 years. They 
reported receiving the diagnosis a mean of 3.8 years previously, at the average age of 58 years 
(range 37-65). Just over half had Alzheimer’s disease and the next most common diagnosis 
(n=30,12.9%) was a variant of fronto-temporal dementia; the rest reported a variety of diagnoses, 
with 18 (7.7%) not knowing or not reporting dementia type. They were taking on average over four 
prescription medications. A small number reported being in paid employment, living alone or in a 






care home; just over 10% reported having children living in the household.  Just over a quarter of 
those with YOD were not comfortable to remain home alone at all; just under a quarter were  
comfortable to be alone for 24 hours or longer (Table 1).    
 
Most family members were spouses and female, with a mean age of 59 years. They were taking on 
average one prescription medication. Over one third were in paid employment and more than half 
reported giving up work to provide care. Those in employment were, on average, younger (58.9 vs 
63.7 years) and there was less time since diagnosis (2.7 vs 4.5 years; both, independent t test 
p<0.0005) (Table 1). 
 
The annual household income reported for the person with YOD was low, with a third reporting this 
to be under £12,000 and almost a further third reporting income between £12,001 and £20,000 (data 





Over a third of respondents received their diagnosis in a memory clinic, around a quarter  in 
Neurology; with under a fifth  in older people’s mental health services or a specialist YOD service 
(Table 2). Eighty-six percent of respondents reported that both brain scans and memory tests were 
used during assessment. Around 40% of respondents reported receiving no follow-up during the 6-
weeks after diagnosis. Rates varied significantly between types of service, being lowest (22%) in 
specialist YOD services and highest (61%) in Neurology (See supplementary material: S2, for 
detail).   
 






Management of ongoing care  
Care arrangements varied. About one fifth reported their care was managed solely by a specialist 
YOD service and another fifth solely by a GP. The rest reported a range of single service 
arrangements or shared care; around 16% reported nobody managed their care. Those in rural areas 
were more likely to be receiving care from their GP alone (Table 2).  
 
Almost half of those diagnosed in specialist YOD services continued to receive ongoing care from 
those services, whereas under a quarter who were diagnosed in another type of service received 
ongoing care from that same type of service. The rest were discharged to GP care (alone or shared), 
referred to another service, reported no on-going management or didn’t answer the question. Of 
those who did not know who regularly managed their care, 40% had been diagnosed in a memory 
clinic and a quarter in neurology. Nearly one third of all respondents reported having no routine 
follow-up appointments. Frequency for those who did have appointments varied widely. There was 
no significant difference between service types, urban or rural location, diagnosis or time since 




Professionals seen and activities attended  
Approximately 39% reported that the person with YOD had seen no health professional in the last 
three months. The proportion was highest among those whose care was managed by GPs alone and 
lowest among those whose care was managed in a specialist YOD service. Sixteen different types of 
health or social care professionals were listed as involved in care, the most common being mental 
health nurses, social workers, and psychiatrists. Of other service contacts in the last three months, 






just over half had attended social activities, around a quarter had a visiting home carer and an eighth 




Family care  
Almost 60% of family members reported spending more than 5 hours per day supervising/helping 
the person with YOD and over 40% reported spending an additional 15 hours per week or more on 
household tasks since the diagnosis. Just over one quarter reported that an organisation took care of 
the person with YOD for some time on a weekly basis but about 70% reported no regular respite. 
Just under a third reported occasional attendance at a carer support group (Table 3).   
 
Eighty-three (44.9%) reported having relatives or friends helping with care. Total hours of help per 
day in the last three months from other relatives and friends showed a mean of 6.1, SD 4.08, median 
8, range 0 - 25.5, IQR 2.5 - 8.3. The maximum hours per day of 25.5 were reported for three 
respondents where one family member provided 1-2 hours per day and other relatives/friends 
provided support 24/7. 
 
Costs of care 
Costs of care (£, 2018), over 3 months, are summarised in Table 4. The cost of family care 
dominated but the distribution was highly skewed. Summed costs of all health and social/home care 
were under £750 on average (median <£400), whereas estimated average costs for the hours 
families spent in providing care were almost £10,000 (median >£8,000).  Only just over a quarter 
(56 of 229) of people with YOD were reported as having home/social care, with a mean cost, where 






this was provided, of just over £1,000 over three months. Costs by survey completion pathway are 




Quality and satisfaction with care 
Specialist YOD services performed better than other services on all quality indicators. In specialist 
YOD services, almost all reported seeing the same professional at each appointment whereas this 
was the case for only just over half of those whose care was managed solely by their GP. Under a 
third of the overall sample reported having a care plan and the number with a key worker was not 
much higher (38%), though in specialist YOD services it was 76.3% (Table 5). 
 
Around 60% of respondents reported that their care was mostly or very good whilst 24% felt their 
care was mostly or very poor, the rest being equivocal. The mean scores suggest people receiving 
care from specialist YOD services were most satisfied. Family members completing the survey 
alone expressed lower service satisfaction than was expressed through other completion pathways 
(Table 5). 
 
<TABLE 5>  
 
Regression modelling  
Five variables explained 30.2% of the variation in satisfaction scores. Knowing who to contact, 
being managed in a specialist YOD service and living in the south-east of England were positively 
associated with satisfaction; reporting nobody or a GP alone managing care on a regular basis were 
associated with lower satisfaction.  







Total costs of health and social care over three months were associated with the amount of time the 
person with YOD could comfortably be left alone (higher cost with less time person could be left 
alone), dementia diagnosis (Alzheimer’s less cost than any other type) and region (higher cost in 
south-east England) but this model explained only 12% of variation in costs.  
 
Hours of care provided by family per day were predicted by the amount of time the person with 
YOD could comfortably be left alone (more caring hours when person could be left alone for less 
time), the service managing care (more caring hours when shared care with GP) and region (more 






This UK survey has established information about services used by people living with YOD in 
England. The findings highlight the variation in routes to assessment and diagnosis and in ongoing 
care management arrangements. Although diagnosis in Neurology or mental health services 
facilitates exclusion of other mental or physical health conditions, a disadvantage was the lack of 
continuity in the care pathway to ongoing care management. The proportion of respondents 
receiving ongoing management through the service that had provided diagnosis was under a quarter 
in all settings, except specialist YOD services where it approached half. Also, the majority of those 
who did not know who regularly managed their care had been diagnosed in memory clinics or 
neurology.  
 






As identified in other research 11, the data confirm distinctive needs associated with YOD in relation 
to family issues (10% had children at home); employment-related issues (5.6% were still working) 
and financial impact (over half of family members had given up work to care and a high proportion 
reported relatively low household income).  
 
Consistent with the findings of Mayrhofer et al.’s review 11,, however, there was considerable 
variation in who respondents reported as co-ordinating their ongoing care, with only about 1 in 5 
managed by specialist services. Overall, the lack of support was striking: 42% reported no follow-
up within 6 weeks of diagnosis; 16% reported that no service managed their ongoing care; during 
the previous three months, almost half had attended no social activities for people with dementia, 
over 80% had no contact with a dementia-related charitable body (e.g. Alzheimer’s Society) and 
around 70% of family members had neither attended a carers’ group nor had any organisation to 
provide care to give them a break. While it is possible that many people with YOD, and supporting 
family members, chose to manage without support, it also seems possible that appropriate services 
were not available 17 or there was no sign-posting information 22.  
 
The survey confirmed suggestions from previous work 8-13 that care is superior in specialist YOD 
services. Those diagnosed in specialist services were far more likely to receive a follow-up 
appointment within 6 weeks of diagnosis and more likely to have ongoing care management 
appointments at least quarterly. People diagnosed in YOD services were more likely to receive 
ongoing care management from the same service and were more likely to see the same professional 
at each appointment. More of those attending specialist YOD services reported having a care plan. 
Satisfaction scores were higher when care was provided through a specialist YOD service or a 
shared care arrangement. These findings were confirmed by regression modelling in which being in 
receipt of specialist YOD services made a positive contribution to service satisfaction. Whilst 






overall satisfaction varied, and low services use was reported 8, many people were satisfied with 
their care and offered examples of good quality support (reported elsewhere, 19.  
 
The survey showed the significant contribution to caring by family members which dominated the 
costs of care. Median formal health and social care costs for those with YOD were under £400 
compared to the estimated £8,000 costs per family per three months. Costs of care of older people 
with dementia also show that unpaid care dominates23. Average formal health and social care costs 
for older people with moderate dementia in the community in their second year post-diagnosis have 
been estimated as £2988 (£:2015) and family costs as £5184 (£:2015)23. It is notable that our survey 
found lower service costs and higher family costs for YOD than calculated for older people with 
dementia. Regression modelling confirmed that costs were positively related to the level of 
independence of the person with dementia, proxied by the amount of time they could be left alone, 
as also found for all-age dementia care23.  
 
One unexpected finding was that those with YOD were being prescribed significantly more 
medications than family members/supporters, even though they were similar in many aspects of 
social demography. Even though their medications may have included an anti-dementia medication, 
this difference raises an issue about the health and medication use of those with YOD which may be 
worthy of further exploration, particularly given previous research indicates high levels of 
psychotropic drug prescription for people with YOD living in the community24. The significant 
contribution of region, to respondents’ satisfaction with services, service costs and amount of 
family care, implies possible geographical variation in provision 16. This could imply the need to 
level up services across the UK or could be due to regional cultural differences. 
 
Strengths and limitations 






The survey achieved a large sample with over half of responses directly involving people living 
with YOD. A reasonable representation across UK regions, types of dementia, age of onset, current 
life situation and degree of independence/dependence was achieved. Although mean time since 
diagnosis (3.8 years) was relatively short, there was a relatively even split of those providing care 
for under, and over, 5 hours per day (42.7% vs 57.3%), and in the extent to which people with YOD 
could be at home alone, implying a reasonable degree of variation in extent of impairment due to 
dementia.   
 
While this was the largest UK study focused on services for YOD to date, the numbers of those 
with rarer dementias were small, leading to a decision to combine a range of different diagnoses 
into an ‘other’ category for comparative analyses. Consequently, we were unable to discern 
different patterns between diagnostic groups. Furthermore, people with more severe cognitive 
impairment may have been under-represented. These areas deserve further investigation, in 
particular to consider the service profile and satisfaction of those with FTD, given the distinctive 
impact of FTD diagnoses. In addition, the survey relied on self-report from those with dementia or 
their supporters so information may include errors. Compromises in the survey questions were 
made to achieve a balance between accessibility and comprehensiveness, which means some detail 
could not be precisely gathered. 
 
Clinical implications 
The findings demonstrate that specialist YOD services provide higher quality care both by objective 
indicators and in satisfaction ratings by people with YOD and family members. This, in the context 
of wider evidence that interventions and activities provided in generic dementia services are 
inappropriate and unacceptable for those with YOD15,17,18, implies that local commissioners should 
seek to configure dementia services to include specialist YOD teams. Where diagnosis does not 






take place in a specialist YOD service, attention needs to be paid to transitional arrangements 
between diagnosis and post-diagnostic support.  
 
Conclusions 
There is great variation within diagnostic care pathways and ongoing care management for YOD in 
the UK, leading to disparate experiences. Overall, our survey respondents received few services and 
absorbed few resources. Specialist YOD services were associated with better continuity, quality and 
satisfaction and appeared to be in the best position to meet care needs. However, respondents in 
receipt of specialist care were in the minority, indicating that further specialist services should be 
commissioned. Family members are providing significant amounts of care on a daily basis with 
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